GlassScriptPhysician profile
Jennifer Jackson
NPI 1477138568
$1,062.16
in general payments reported to CMS, 2019-2025
20 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $515 · 2023: $226 · 2024: $30.48 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.33 | 2022 | |
| Kestra Medical Technology Services, INC. | $135.35 | 2024-2025 | Assure Wcd |
| Dexcom, INC. | $125.56 | 2023 | Dexcom G7 Gss (161) |
| Teva Pharmaceuticals USA, INC. | $121.87 | 2022 | |
| Lilly USA, LLC | $86.54 | 2021-2022 | |
| Astellas Pharma US INC | $74.64 | 2021-2023 | Veozah |
| Abbvie INC. | $71.10 | 2022-2023 | |
| Novo Nordisk INC | $56.47 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.79 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.40 | 2022-2023 | Breztri |
| Corium, LLC | $23.78 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.65 | 2021 | |
| Organon LLC | $20.43 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $16.66 | 2022 | |
| Kaleo, INC. | $15.40 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.82 | 2021 | |
| Redhill Biopharma INC. | $13.70 | 2022 | |
| Daiichi Sankyo INC. | $13.50 | 2023 | Injectafer |
| Amarin Pharma, INC. | $11.22 | 2021 | |
| Sunovion Pharmaceuticals INC. | $10.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.